US Stock MarketDetailed Quotes

BLPH Bellerophon Therapeutics

Watchlist
  • 0.057
  • 0.0000.00%
Trading Mar 28 11:09 ET
695.00KMarket Cap-63P/E (TTM)

About Bellerophon Therapeutics Company

Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Company Profile

SymbolBLPH
Company NameBellerophon Therapeutics
Listing Date02/13/2015
Issue Price12.00
Founded2009
CEOMr. Peter Fernandes
MarketPink Market
Employees18
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address184 Liberty Corner Road,Suite 302
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-574-4770

Company Executives

  • Name
  • Position
  • Salary
  • Nicholas Laccona
  • Principal Financial and Accounting Officer and Secretary
  • --
  • Bobae Kim
  • Vice President, Regulatory Affairs and Quality Assurance
  • --
  • Naseem Amin
  • Chairman of the Board
  • 83.10K
  • Scott P. Bruder
  • Independent Director
  • 84.90K
  • Mary Ann Cloyd
  • Independent Director
  • 97.40K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg